After three years, the federal public health emergency (PHE) will expire May 11, 2023. Most of the relaxed regulatory and payor standards will end on or within a few months after the.
DEA announced proposed permanent rules for prescribing controlled substances via telemedicine and circumstances affecting practitioners ability to prescribe controlled substances without in person medical evaluation of patient outside of COVID 19 public health emergency.
On February 24, 2023, the Drug Enforcement Agency (“DEA”) announced proposed permanent rules around prescribing controlled substances via telemedicine that expand the circumstances.
US Drug Enforcement Administration DEA seeks to establish more pathways for prescription of controlled substances in limited quantities via telehealth without initial in-person medical exam. This practice is allowed during COVID-19 public health emergency ending May 11th.
On February 24, 2023, the US Drug Enforcement Administration (DEA) issued two proposed rules (the Telemedicine Controlled Substance Proposed Rule and the Telemedicine Buprenorphine.